The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.
暂无分享,去创建一个
[1] A. Esterman,et al. How Effective Is Penetrating Corneal Transplantation? Factors Influencing Long-Term Outcome in Multivariate Analysis , 2006, Transplantation.
[2] D. E. Zirm. Eine erfolgreiche totale Keratoplastik , 1906, Albrecht von Graefes Archiv für Ophthalmologie.
[3] Sanjay V. Patel,et al. Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty. , 2005, Transactions of the American Ophthalmological Society.
[4] R. Wolfe. Long‐term Renal Allograft Survival: A Cup Both Half‐Full and Half‐Empty , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] C. Jessup,et al. Gene therapy approaches to prolonging corneal allograft survival , 2004, Expert opinion on biological therapy.
[6] P. McMenamin,et al. The Distribution of Antigen in Lymphoid Tissues following Its Injection into the Anterior Chamber of the Rat Eye1 , 2004, The Journal of Immunology.
[7] Jingtai Cao,et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. , 2004, The Journal of clinical investigation.
[8] L. Missotten,et al. Morphologic and immunophenotypic heterogeneity of corneal dendritic cells , 1991, Graefe's Archive for Clinical and Experimental Ophthalmology.
[9] A. Dick,et al. Development of organised conjunctival leucocyte aggregates after corneal transplantation in rats , 2003, The British journal of ophthalmology.
[10] J. Schold,et al. Overview of Large Database Analysis in Renal Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] W. Hopfenmüller,et al. HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.
[12] J. Streilein. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation , 2003, Journal of leukocyte biology.
[13] M. Sykes,et al. Mechanisms of transplant tolerance induction using costimulatory blockade. , 2002, Current opinion in immunology.
[14] U. Rehany,et al. The conundrum of death, dying and organ donation , 2002, The British journal of ophthalmology.
[15] B. Delbosc,et al. Danger of Systemic Cyclosporine for Corneal Graft , 2002, Cornea.
[16] R. Lechler,et al. Pathways of allorecognition: implications for transplantation tolerance. , 2002, Transplant immunology.
[17] S. Böhringer,et al. Predicting time on the waiting list for HLA matched corneal grafts. , 2002, Tissue antigens.
[18] M. Thiel,et al. Penetration of engineered antibody fragments into the eye , 2002, Clinical and experimental immunology.
[19] U. Stenevi,et al. Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register , 2002, The British journal of ophthalmology.
[20] R. Dana,et al. Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II–positive Dendritic Cells Derived from MHC Class II–negative Grafts , 2002, The Journal of experimental medicine.
[21] D. Gartry,et al. Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study , 2001, The British journal of ophthalmology.
[22] J. Niederkorn. Mechanisms of Corneal Graft Rejection: The Sixth Annual Thygeson Lecture, Presented at the Ocular Microbiology and Immunology Group Meeting, October 21, 2000 , 2001, Cornea.
[23] M. Dana,et al. Role of CD4+ and CD8+ T Cells in Allorecognition: Lessons from Corneal Transplantation1 , 2001, The Journal of Immunology.
[24] S. Klebe,et al. PROLONGATION OF SHEEP CORNEAL ALLOGRAFT SURVIVAL BY EX VIVO TRANSFER OF THE GENE ENCODING INTERLEUKIN-101 , 2001, Transplantation.
[25] R. Dana,et al. The critical role of lymph nodes in corneal alloimmunization and graft rejection. , 2001, Investigative ophthalmology & visual science.
[26] M. Araie,et al. Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty. , 1999, Japanese journal of ophthalmology.
[27] J. Niederkorn,et al. The role of cytotoxic T lymphocytes in corneal allograft rejection. , 2000, Investigative ophthalmology & visual science.
[28] H. Völker‐Dieben,et al. BENEFICIAL EFFECT OF HLA-DR MATCHING ON THE SURVIVAL OF CORNEAL ALLOGRAFTS1 , 2000, Transplantation.
[29] J. Forrester,et al. Campath-1H therapy in refractory ocular inflammatory disease , 2000, The British journal of ophthalmology.
[30] J. Pepose,et al. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. , 1997, The Journal of clinical investigation.
[31] S. Gore,et al. INFLUENCE OF DONOR AND HISTOCOMPATIBILITY FACTORS ON CORNEAL GRAFT OUTCOME , 1994, Transplantation.
[32] P. Holt,et al. Immunomorphologic studies of macrophages and MHC class II-positive dendritic cells in the iris and ciliary body of the rat, mouse, and human eye. , 1994, Investigative ophthalmology & visual science.
[33] N. Nguyen,et al. Aqueous flare following penetrating keratoplasty and in corneal graft rejection. , 1994, Archives of ophthalmology.
[34] J. Hill,et al. Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy. , 1994, Ophthalmology.
[35] P. Laughrea,et al. Risk factors of corneal graft failure. , 1993, Ophthalmology.
[36] M. Jager. Corneal Langerhans cells and ocular immunology. , 1992, Regional immunology.
[37] D. Roder,et al. Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. , 1992, Ophthalmology.
[38] M. Maguire,et al. Reproducibility of HLA-A, B, and DR typing using peripheral blood samples: results of retyping in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Group (corrected) , 1992, Human Immunology.
[39] P. Heering,et al. Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. A retrospective study. , 1992, German journal of ophthalmology.
[40] D. Coster,et al. Leukocytes in the graft bed associated with corneal graft failure. Analysis by immunohistology and actuarial graft survival. , 1989, Ophthalmology.
[41] A. Bill. The blood-aqueous barrier. , 1986, Transactions of the ophthalmological societies of the United Kingdom.
[42] J. Pepose,et al. Detection of HLA class I and II antigens in rejected human corneal allografts. , 1985, Ophthalmology.
[43] D. Coster,et al. HISTOCOMPATIVILITY ANTIGEN AND PASENGER CELL CONTENT OF NORMAL AND DISEASED HUMAN CORNEA , 1985, Transplantation.
[44] R. D. Stulting,et al. The distribution of HLA antigens on human corneal tissue. , 1984, Investigative ophthalmology & visual science.
[45] H. Völker‐Dieben,et al. THE EFFECT OF PROSPECTIVE HLA‐A AND ‐B MATCHING ON CORNEAL GRAFT SURVIVAL , 1982, Acta ophthalmologica.
[46] J. D. Salisbury,et al. Blood group antigens on human corneal cells demonstrated by immunoperoxidase staining. , 1981, American journal of ophthalmology.
[47] P. Medawar. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. , 1948, British journal of experimental pathology.